Home | CE Accreditation | Faculty | Scientific Agenda | Case Vignettes | General Info/Accommodations | Register | Contact

Description
The symposium will be presented in a live format designed to reinforce key learning objectives and engage attendees in an interactive discussion. Pre-conference patient case vignettes will be made available to allow the introduction of new information and concepts in advance of the conference. Participants who complete the vignettes will have a greater opportunity to formulate their questions and ideas for discussion with the experts. The program will take place at The Four Seasons Hotel, Midtown Atlanta, Georgia on Saturday, April 17, 2010.

Statement of Need
Significant improvements have occurred in the management of lung cancer over the past decade. One of the most widely studied approaches to the field of cancer, particularly lung cancer, is treatment strategies incorporating new agents and novel combinations. This is based on an extensive search of the literature in the public domain. Despite these advances, long-term survival benefit has remained elusive. With novel pharmacological agents and treatment strategies, the decision-making process for oncology healthcare professionals involved in the treatment of lung cancer is challenging, thereby requiring in-depth knowledge of current clinical and experimental data for the appropriate integration of new therapeutics into clinical practice. Because of this, healthcare professionals caring for patients with lung cancer need to understand the basis for treatment approaches likely to change clinical practice in the next few years, as well as the preclinical and clinical data supporting the development and integration of these therapies into practice. As such, this program has been developed to provide a comprehensive overview of recent advances in the treatment of lung cancer. The didactic presentation will be combined with discussions on controversial topics in lung cancer management, thus allowing for an interactive exchange of critical clinical information.

Who Should Attend?
The target audience for this educational initiative includes medical oncologists and related professionals caring for patients with lung cancer; pathologists, pulmonologists, oncology pharmacists, oncology nurses, and case managers are also invited to attend.

Learning Objectives
Upon completion of this educational activity, participants should be better able to:

• Describe the most current advances for the diagnosis and staging of patients with lung cancer
• Describe the rationale for the development and integration of new therapeutic approaches in lung cancer
• Discuss the clinical implications of the results from pivotal clinical trials that have impacted the use of new approaches and strategies for the treatment of NSCLC
• Review ongoing clinical trial designs of novel surgical, radiotherapeutic, and chemotherapeutic treatment strategies for the management of NSCLC
• Discuss supportive care issues and side effect management required for patients with lung cancer 

Accreditation Information

Physician Continuing Education
Accreditation Statement
Educational Concepts Group, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Educational Concepts Group, LLC designates this educational activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education
	Educational Concepts Group, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Type of Activity: Knowledge-based

Educational Concepts Group, LLC designates this continuing education activity for 7.0 contact hours (0.70 CEUs). (UAN 0199-0000-10-053-LO1-P).

CME/CE Credit
A statement of credit will be issued only upon receipt of a completed activity evaluation form. Your statement of credit will be available to view and print via the ECG website, www.educationalconcepts.net, 6 weeks after the activity.

Disclosure of Financial Relationships with Any Commercial Interest
As a sponsor accredited by the ACCME, it is the policy of ECG to require that everyone who is in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest and identify and resolve all conflicts of interest prior to the educational activity. The ACCME defines “relevant financial relationships” as any amount occurring within the past 12 months. Faculty who refuse to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity. For an individual with no relevant financial relationship(s), the participants must be informed that no relevant financial relationship(s) exist. If ECG determines that a potential conflict of interest exists as a result of a personal financial relationship, mechanisms will be instituted to resolve this conflict prior to the activity. ECG has implemented a content validator role. That role is to ensure that the activity materials are fair-balanced, scientifically sound, and free of bias toward the commercial supporter(s) of the activity or manufacturers of products discussed in the activity. In addition, faculty members are expected to disclose discussion of any unlabeled use of a commercial product, or an investigational use not yet approved for any purpose. ECG is committed to providing learners with high-quality, unbiased, and state-of-the-art education.

ECG has Declared the Following Financial Relationships
ECG receives educational grants from pharmaceutical industry and other commercial sources. Planners, managers, and other staff members at ECG have no relevant financial relationships to disclose.

Fee Information
The fees for this educational activity cover participation at all symposium sessions, meeting materials, food functions as listed on the agenda, and continuing education processing.

• Physician $100
• PA/NP $75
• Fellow $65
• Nurse/Pharmacist $65
• Other healthcare professional $50
• Industry $1000

Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie: physical, dietary, etc). Please contact Jackie Falconer prior to the live event at 1.770.933.1696.

CME/CE Inquiries
For further information, please contact:
Educational Concepts Group, LLC 
1300 Parkwood Circle SE, Suite 325
Atlanta, Georgia 30339
Phone: 1.770.933.1681
Fax: 1.770.933.1692
www.educationalconcepts.net